- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Investment giants join forces to form largest healthcare firm on the globe | ||
| Mi | Clinical Trials Day 2026: 'Research Rising' theme reflected in Q1 study growth | ||
| Mi | Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict | ||
| Mi | QIAGEN and NVIDIA partner on AI drug discovery | ||
| Mi | SERB signs agreement to acquire Idefirix rights for $133.6m | ||
| Di | UK government bolsters antiviral supply for hantavirus | ||
| Di | VERTANICAL's VER-01 gains FDA breakthrough status for low back pain | ||
| Di | Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates | ||
| Mo | Vaccine void means current Ebola outbreak declared international emergency | ||
| Mo | Tracy Beth Høeg ousted from FDA in wider senior leadership shakeup | ||
| Mo | Japan's MHLW approves Boehringer's Jascayd for IPF and PPF | ||
| Mo | FDA approves Enhertu for two HER2-positive early breast cancer indications | ||
| Fr | Nonprofits join forces to debut marketplace for shelved CGTs | ||
| Fr | Arna Pharma and Slate Run complete JV for new US company | ||
| Fr | Biopharma industry endorses Pazdur for FDA commissioner role | ||
| Fr | Kyowa Kirin secures FDA approval for Crysvita dosing update | ||
| 14.05. | UK health secretary Wes Streeting resigns | ||
| 14.05. | Coya Therapeutics secures FDA fast track status for COYA 302 | ||
| 14.05. | Regulatory round-up: A month of key FDA approvals for cancer drugs | ||
| 14.05. | Imfinzi set to become first immunotherapy for stomach cancer patients on NHS | ||
| 14.05. | Zydus to acquire Assertio in $166m deal | ||
| 14.05. | Pfizer receives EC approval for Hympavzi to treat haemophilia | ||
| 13.05. | EU advances plans to reduce reliance on drug imports | ||
| 13.05. | UAE approves AstraZeneca's Baxfendy for hypertension | ||
| 13.05. | Isomorphic Labs receives $2.1bn for AI drug development |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.